Zeposia Initiation Pack TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ozanimod
Pack: Zeposia Initiation Pack (4 x 230 microgram capsules, 3 x 460 microgram capsules), 7, blister pack
Brand name
(ARTG)
: ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Sclerosis ZEPOSIA is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis.,Ulcerative Colitis ZEPOSIA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Capsule
- Oral
- Size 4 opaque hard shell capsules with light grey body and light grey cap. Imprinted in black ink with 'oza' on cap and '0.23 mg' on the body.
Component :
- Capsule
- Oral
- Size 4 opaque hard shell capsules with light grey body and orange cap. Imprinted in black ink with 'oza' on cap and '0.46 mg' on the body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 7 capsules (4 x 230 microgram capsules and 3 x 460 microgram capsules) pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ozanimod
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
